Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
Metro G, Baglivo S, Bellezza G, Mandarano M, Gili A, Marchetti G, Toraldo M, Molica C, Reda MS, Tofanetti FR, Siggillino A, Prosperi E, Giglietti A, Di Girolamo B, Garaffa M, Marasciulo F, Minotti V, Gunnellini M, Guida A, Sassi M, Sidoni A, Roila F, Ludovini V. Metro G, et al. Among authors: roila f. Genes (Basel). 2021 Apr 30;12(5):679. doi: 10.3390/genes12050679. Genes (Basel). 2021. PMID: 33946594 Free PMC article.
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Ludovini V, Bianconi F, Siggillino A, Vannucci J, Baglivo S, Berti V, Tofanetti FR, Reda MS, Bellezza G, Mandarano M, Belladonna ML, Metro G, Chiari R, Sidoni A, Puma F, Minotti V, Roila F. Ludovini V, et al. Among authors: roila f. Genes (Basel). 2021 Feb 15;12(2):273. doi: 10.3390/genes12020273. Genes (Basel). 2021. PMID: 33671892 Free PMC article.
Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma.
Metro G, Signorelli D, Pizzutilo EG, Giannetta L, Cerea G, Garaffa M, Friedlaender A, Addeo A, Mandarano M, Bellezza G, Roila F. Metro G, et al. Among authors: roila f. Hum Vaccin Immunother. 2021 Sep 2;17(9):2972-2980. doi: 10.1080/21645515.2021.1917933. Epub 2021 May 18. Hum Vaccin Immunother. 2021. PMID: 34003722 Free PMC article.
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy.
Baglivo S, Bianconi F, Metro G, Gili A, Tofanetti FR, Bellezza G, Ricciuti B, Mandarano M, Teti V, Siggillino A, Reda MS, Chiari R, Pistola L, Sidoni A, Minotti V, Roila F, Ludovini V. Baglivo S, et al. Among authors: roila f. Genes (Basel). 2021 Jun 29;12(7):992. doi: 10.3390/genes12070992. Genes (Basel). 2021. PMID: 34209514 Free PMC article.
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis.
Metro G, Gili A, Signorelli D, De Toma A, Garaffa M, Galetta D, Economopoulou P, Friedlaender A, Jimenez B, Collazo-Lorduy A, Addeo A, Chiarini P, Costa C, Mountzios G, Roila F. Metro G, et al. Among authors: roila f. Clin Transl Oncol. 2021 Sep;23(9):1818-1826. doi: 10.1007/s12094-021-02588-8. Epub 2021 Mar 16. Clin Transl Oncol. 2021. PMID: 33728869
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool.
Mandarano M, Bellezza G, Belladonna ML, Vannucci J, Gili A, Ferri I, Lupi C, Ludovini V, Falabella G, Metro G, Mondanelli G, Chiari R, Cagini L, Stracci F, Roila F, Puma F, Volpi C, Sidoni A. Mandarano M, et al. Among authors: roila f. Front Immunol. 2020 May 27;11:839. doi: 10.3389/fimmu.2020.00839. eCollection 2020. Front Immunol. 2020. PMID: 32536910 Free PMC article.
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%.
Metro G, Banna GL, Signorelli D, Gili A, Galetta D, Galli G, Economopoulou P, Roila F, Friedlaender A, Camerini A, Christopoulou A, Cantale O, De Toma A, Pizzutilo P, Jimenez B, Collazo-Lorduy A, Calles A, Baxevanos P, Linardou H, Kosmidis P, Giannarelli D, Mountzios G, Addeo A. Metro G, et al. Among authors: roila f. J Immunother. 2020 Nov/Dec;43(9):299-306. doi: 10.1097/CJI.0000000000000340. J Immunother. 2020. PMID: 32991393
237 results